ticlopidine has been researched along with Foot Ulcer in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Foot Ulcer: Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegemann, B | 1 |
| Helmbold, P | 1 |
| Marsch, WC | 1 |
1 other study available for ticlopidine and Foot Ulcer
| Article | Year |
|---|---|
Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences.
Topics: Antithrombin III Deficiency; Female; Follow-Up Studies; Foot Ulcer; Humans; Male; Middle Aged; Pento | 2002 |